112 related articles for article (PubMed ID: 28691251)
41. [Direct reporting by patients of adverse drug reactions in Spain].
Esther Salgueiro M; Jimeno FJ; Aguirre C; García M; Ordóñez L; Manso G
Farm Hosp; 2013; 37(1):65-71. PubMed ID: 23461502
[TBL] [Abstract][Full Text] [Related]
42. Fatal adverse drug reactions of anticancer drugs detected by all-case post-marketing surveillance in Japan.
Mori J; Tanimoto T; Miura Y; Kami M
Jpn J Clin Oncol; 2015 Jun; 45(6):588-94. PubMed ID: 25759486
[TBL] [Abstract][Full Text] [Related]
43. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
Wysowski DK; Swartz L
Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
[TBL] [Abstract][Full Text] [Related]
44. Ophthalmic adverse drug reactions to systemic drugs: a systematic review.
Miguel A; Henriques F; Azevedo LF; Pereira AC
Pharmacoepidemiol Drug Saf; 2014 Mar; 23(3):221-33. PubMed ID: 24464938
[TBL] [Abstract][Full Text] [Related]
45. Classification of nervous system withdrawn and approved drugs with ToxPrint features via machine learning strategies.
Onay A; Onay M; Abul O
Comput Methods Programs Biomed; 2017 Apr; 142():9-19. PubMed ID: 28325450
[TBL] [Abstract][Full Text] [Related]
46. [Vigilance for veterinary medicinal products: Reports of adverse reactions in the year 2015].
Müntener C; Kupper J; Naegeli H; Gassner B
Schweiz Arch Tierheilkd; 2016 Nov; 158(11):743-747. PubMed ID: 27821377
[TBL] [Abstract][Full Text] [Related]
47. Analysis of safety-related regulatory actions by Japan's pharmaceutical regulatory agency.
Ishiguro C; Misu T; Iwasa E; Izawa T
Pharmacoepidemiol Drug Saf; 2017 Nov; 26(11):1314-1320. PubMed ID: 28722235
[TBL] [Abstract][Full Text] [Related]
48. [Biosimilars].
Krämer I
Ther Umsch; 2011 Nov; 68(11):659-66. PubMed ID: 22045529
[TBL] [Abstract][Full Text] [Related]
49. [Pharmacovigilance off the beaten track: herbal surveillance or pharmacovigilance of medicinal plants].
Castot A; Djezzar S; Deleau N; Guillot B; Efthymiou ML
Therapie; 1997; 52(2):97-103. PubMed ID: 9231502
[TBL] [Abstract][Full Text] [Related]
50. [The new pharmacovigilance legislation in practice].
Broekmans AW; Mol PG
Ned Tijdschr Geneeskd; 2014; 158():A7129. PubMed ID: 24846112
[TBL] [Abstract][Full Text] [Related]
51. Food and Drug Administration monitoring of adverse drug reactions.
Sills JM; Tanner LA; Milstien JB
Am J Hosp Pharm; 1986 Nov; 43(11):2764-70. PubMed ID: 3799612
[TBL] [Abstract][Full Text] [Related]
52. Postmarketing evaluations help determine contraceptive safety, efficacy.
Netw Res Triangle Park N C; 1988; 9(2):1-2, 7. PubMed ID: 12280950
[TBL] [Abstract][Full Text] [Related]
53. SAFETY PROFILE OF OCRIPLASMIN FOR SYMPTOMATIC VITREOMACULAR ADHESION: A Comprehensive Analysis of Premarketing and Postmarketing Experiences.
Hahn P; Chung MM; Flynn HW; Huang SS; Kim JE; Mahmoud TH; Sadda SR; Dugel PU
Retina; 2015 Jun; 35(6):1128-34. PubMed ID: 25635575
[TBL] [Abstract][Full Text] [Related]
54. Is spontaneous reporting always the most important information supporting drug withdrawals for pharmacovigilance reasons in France?
Paludetto MN; Olivier-Abbal P; Montastruc JL
Pharmacoepidemiol Drug Saf; 2012 Dec; 21(12):1289-94. PubMed ID: 22961933
[TBL] [Abstract][Full Text] [Related]
55. Postmarketing safety surveillance of trivalent recombinant influenza vaccine: Reports to the Vaccine Adverse Event Reporting System.
Woo EJ; Moro PL; Cano M; Jankosky C
Vaccine; 2017 Oct; 35(42):5618-5621. PubMed ID: 28886946
[TBL] [Abstract][Full Text] [Related]
56. Evaluating the completeness and accuracy of MedWatch data.
Getz KA; Stergiopoulos S; Kaitin KI
Am J Ther; 2014; 21(6):442-6. PubMed ID: 23011177
[TBL] [Abstract][Full Text] [Related]
57. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
Theriaca; 2016; (43):9-61. PubMed ID: 27491172
[TBL] [Abstract][Full Text] [Related]
58. National adverse drug reaction surveillance: 1985.
Faich GA; Knapp D; Dreis M; Turner W
JAMA; 1987 Apr; 257(15):2068-70. PubMed ID: 3560382
[TBL] [Abstract][Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
